Assessment Tools
MASCC Antiemesis Tool © (MAT)
The MASCC Antiemesis Tool (MAT) is an easy-to-use and easy-to-evaluate tool designed to help cancer patients and professionals communicate accurately about the prevention and control of nausea and vomiting that may occur with chemotherapy. The MAT can also help treatment centers evaluate the effectiveness of their antiemetic strategies.
Available in 18 language and as an app.
MASCC Unmet Needs Assessment of Cancer-Related Cognitive Impairment Impact © (MASCC COG-IMPACT)
The MASCC COG-IMPACT is the first purpose-built multi-domain unmet needs assessment for cancer-related cognitive impairment impact. It is a fit-for-purpose self-report tool that assesses the difficulties and unmet needs directly related to CRCI. The tool is designed to support health professionals in providing highly individualized and optimal care to cancer survivors as well as facilitate appropriate referral, support service provision, guide further assessment, and inform clinical and healthcare discussions. The MASCC COG-IMPACT can also be used by researchers aiming to better understand, or minimize the impact of, cancer-related cognitive impairment on the lives of cancer survivors.
MASCC EGFR Inhibitor Skin Toxicity Tool © (MESTT)
The MASCC EGFR Inhibitor Skin Toxicity Tool© (MESTT) assists health providers with the monitoring and reporting of dermatologic adverse effects in patients treated with epidermal growth factor receptor (EGFR) inhibitors. The MESTT is an event-specific grading system that can be used to:
- Standardize assessment,
- Optimize the use of EGFR inhibitors
- Enable researchers to conduct more informative, controlled studies
MASCC Oral Agent Teaching Tool © (MOATT)
The MASCC Oral Agent Teaching Tool© (MOATT) is a well-researched, easy-to-use patient education tool designed for use by healthcare providers in clinical practice. Providers can use the MOATT to:
- Guide patient teaching
- Provide comprehensive, standardized instruction (while allowing for individualization)
- Encourage adherence to oral chemotherapy treatment
Available in 9 languages
